Podcast: Play in new window | Download
The Big Ones
When SoftBank emerged with a $9.5bn rescue package for beleaguered workspace provider WeWork in October, $3bn of the amount had been earmarked for a tender that would have involved it buying shares from existing investors and shareholders – likely including hotel chain Jin Jiang International and Legend Capital. However, the company has sent a letter to the shareholders stating that it believes regulatory probes into the WeWork business frees it from that obligation. It’s an interesting approach, but considering SoftBank’s influence at the company even before its IPO attempt, one that may be hard to follow through with.
Speaking of everyone’s favourite corporate. SoftBank’s efforts to raise capital for a second Vision Fund have been largely unsuccessful so far, but it is reportedly seeking $10bn, including $5bn from external backers, to shore up portfolio companies in the face of the Covid-19 pandemic, and maybe acquire rivals struggling with the same issues. Some of the portfolio companies set to be affected include Uber, WeWork, Didi Chuxing and Oyo, though others such as Slack, Paytm and DoorDash could find their business models strengthened by the virus and related social distancing.
Fox has agreed to buy online streaming service Tubi for $440m in cash, allowing MGM and Lionsgate to exit. Both contributed to Tubi’s $6m series A round, part of the $31m in funding it had disclosed prior to the acquisition. Fox should still have a big chunk of the Disney money it got from the 21st Century Fox purchase so it won’t be a surprise to see some more big acquisitions from it coming up soon.
In crossover news, Circle Pharma, a US-based oncology therapeutics spinout of UC San Francisco and UC Santa Cruz, has secured $45m in a series B round backed by UC Berkeley’s investment vehicle, Berkeley Catalyst Fund. Healthcare-focused venture capital fund Column Group led the round, which also included pharmaceutical firm ShangPharma, Nextech Invest and LifeForce Capital. Circle began operations when pharmaceutical firm Pfizer and Mission Bay Capital supplied an undisclosed amount of seed funding in 2014. ShangPharma added an undisclosed sum to the round in mid-2016.
Despite recent reports it was set to merge with key competitor Grab, ride hailing platform Gojek has raised $1.2bn in funding, reportedly bringing its series F round to nearly $3bn. The round already included Tencent, JD.com, Google, AIA, Mitsubishi, Visa, Siam Commercial Bank and Astra International, but no word yet on the identities of the new investors.
AI and imaging technology provider SenseTime has reportedly dropped plans for a Hong Kong IPO and is instead pursuing between $500m and $1bn in new funding. Its existing investors include Alibaba, Qualcomm, Suning and Dalian Wanda, and reports last year suggested its valuation could have reached $7.5bn. In any case, it’s possible a by-product of the coronavirus could be another push back in the IPO space leading to more late-stage rounds.
Plant-based meat product supplier Impossible Foods has raised $500m in series F funding and, in a sign of things to come, told Forbes it will use the money to offset expected difficulties caused by the ongoing coronavirus pandemic. The GV-backed company has reportedly now secured about $1.25bn in funding altogether, and the latest round was led by Mirae Asset Global Investments.
Digital currency technology developer Bakkt has secured $300m as it prepares to expand its crypto wallet to a more diversified crypto services app. The series B funding came from Microsoft unit M12, Naspers subsidiary PayU, Boston Consulting Group, CMT Digital and Intercontinental Exchange, the exchange operator that had spun off Bakkt in the first place.
Data streaming software provider Confluent is reportedly seeking $200m to $300m in a round that could double its valuation to $5bn. Its early investors include LinkedIn, which developed the open source Apache Kafka software on which the company relies. The funding would hypothetically be raised prior to an IPO taking place. Enterprise software has been one of the more resilient sectors of late, especially post-IPO, so that wouldn’t be a huge shock.
StackPath has secured $216m in a series B round co-led by corporates Juniper Networks and Cox Communications, following a $180m series A round revealed when it came out of stealth in 2016. Both leads took board seats at the edge computing technology developer, which plans to put the funding toward enhancing engineering and product development while commercialising its system.
Airwallex is meanwhile looking to raise $200m in a series D round set to be led by an as-yet unnamed financial services provider. The cross-border remittance service has so far secured just over $200m, with approximately half coming in a Tencent-led series C round a year ago that valued it at $1bn. The prospective round would be raised at a $1.5bn pre-money valuation.
Novo has participated in a $100m series G round for drug development software provider Tempus that valued it at $5bn post-money. The participants in the round had all previously contributed to the company’s last round, a $200m series F that closed in May 2019, the funding being raised at a $3.1bn valuation. It will use the series G proceeds to expand the range of conditions its technology serves.
Sigilon Therapeutics is developing bio-engineered cells to treat chronic illnesses without a patient’s immune system rejecting the treatment, and has completed an $80.3m series B round that lifted its overall funding to more than $195m. The round’s participants included Eli Lilly, already an equity investor as of a 2018 collaboration agreement that could potentially top $470m should all milestones be reached.
Engineered T cell therapy developer Eureka Therapeutics has bagged $45m in a series E round led by Lyell Immunopharma, which invested through a strategic partnership deal. Eureka has now raised approximately $134m altogether and will work with Lyell on solid tumour treatments, its own liver cancer candidate having entered phase 1/2 clinical trials.
Cryptocurrency exchange operator Binance has joined forces with its India-based subsidiary WazirX to launch a $50m fund that will invest in blockchain technology developers located in India. The Blockchain for India fund follows a decision by the country’s supreme court to allow financial services firms to take on blockchain companies as clients. As a result, cryptocurrency exchanges in the country are now also able to offer bank account transfers. Apart from providing funding, the vehicle will also look to incubate startups and support blockchain initiatives within universities.
Congruent Ventures, the venture capital firm anchored by University of California, is aiming to raise $125m for its second, sustainability-focused fund, according to a regulatory filing. The filing states Congruent Ventures II is still to raise capital. None of its potential limited partners have been identified. Founded in 2017, Congruent backs early-stage startups that advance sustainability objectives in areas such as urbanisation and mobility, clean energy, food and agriculture and industrial and supply chains. The first Congruent fund closed at $92m in 2018 with a $50m contribution from University of California’s Office of the Chief Investment Officer in addition to Prelude Ventures and undisclosed additional investors.
These are a different kind of exit, but Vietnam-based conglomerate Vingroup has shut down its corporate venturing unit, Vingroup Ventures. Founded in Ukraine in 1993, Vingroup moved into Vietnam in 2000 and has concentrated its activities in the country since then. Its main areas of interest include technology, manufacturing and a range of services in sectors including education, health and real estate. Vingroup established its CVC unit in late 2018 and had targeted $100m of investments across the globe according to its LinkedIn page, though it has failed to disclose a single deal in which it had participated.
DuPont Ventures, the corporate venturing subsidiary of chemicals producer DuPont, is set to close at the end of this month, according to a person familiar with the matter. Formed by DuPont in 2003, its investments have included deals for biofuel feedstock supplier NexSteppe, taste modification molecule developer Linguagen and ethernet services provider Actelis Networks. However, the unit has been relatively quiet of late, its last disclosed investment being its participation in a $75m round for Indiana University’s drone management software spinout PrecisionHawk in early 2018. DuPont Ventures’ closure comes as part of a restructuring that will involve the company’s larger corporate innovation activities being cut as part of a cost-saving process. The firm has not revealed whether it plans to divest the existing equity stakes held by its subsidiary.
“Funky Chunk” Kevin MacLeod (incompetech.com)
Licensed under Creative Commons: By Attribution 3.0